Clinical Trials Browser

Phase 3 × Prostate Adenocarcinoma × Adjuvants, Pharmaceutic × Clear all

NCT02175212 2020-11-20

AADLPC

Phase 3 Completed

362 enrolled 17 charts

Prostate Adenocarcinoma